Clinical trial · Observational
Surgical Approach in Liver Hemangiomas
Surgical Approach in Liver Hemangiomas With Special Emphasis on Lesion Diameter and Type of Surgery
NCT04669314CI-TRIAL-00048865completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Operations performed for liver hemangioma between January 2017 and December 2018 will be retrospectively analyzed.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hemangioma Liver | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Liver resection or enucleation for liver hemangioma | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Complications
- timeFrame
- Complications reported within 3 months after surgery will be evaluated within 15 days after completion of data collection
- description
- Complications after surgery for hemangioma will be collected from records and and will be classified according to 'The Clavien-Dindo Classification of Surgical Complications'. The classification grades are ranging between Grade 1(better) which indicates minor deviation from normal postoperative course and Grade 5 (worst) which means death as a complication.
Secondary outcomes (2)
- measure
- Hospital stay
- timeFrame
- Hospital stay starting with operation and ends with discharge will be compared within 15 days after completion of data collection
- description
- Length of hospital stay postoperatively
- measure
- Transfusion
- timeFrame
- Erythrocyte transfusion during surgery will be analyzed within 15 days after completion of data collection
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients underwent surgery for liver hemangioma Exclusion Criteria: * Cases lacking of more than 20% of critical data
References
Publications (0)
Data not yet available
No reference posted for this study.